BeyondSpring Inc. (BYSI) stock
BYSINasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.56−0.02 (-3.27%)
Close on Nov 17, 2026Market cap $23.02MP/E –Yield –
BeyondSpring operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
BeyondSpring's operating cash flow for the twelve months ending Jun 30, 2026 was -$16.75M. For fiscal 2025 it was -$19.77M. The highest annual figure on record is -$1.15M in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$19.77M | – |
| FY2024 | Dec 31, 2024 | -$16.44M | – |
| FY2023 | Dec 31, 2023 | -$16.47M | – |
| FY2022 | Dec 31, 2022 | -$28.15M | – |
| FY2021 | Dec 31, 2021 | -$47.24M | – |
| FY2020 | Dec 31, 2020 | -$43.75M | – |
| FY2019 | Dec 31, 2019 | -$48.16M | – |
| FY2018 | Dec 31, 2018 | -$39.96M | – |
| FY2017 | Dec 31, 2017 | -$28.80M | – |
| FY2016 | Dec 31, 2016 | -$13.70M | – |
| FY2015 | Dec 31, 2015 | -$6.57M | – |
| FY2014 | Dec 31, 2014 | -$1.15M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.77M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.28M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.50M | -660.5% |
| Q3 FY2025 | Sep 30, 2025 | -$4.19M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.87M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.20M | – |
| Q4 FY2024 | Dec 31, 2024 | $982.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.17M | -282.9% |
| Q2 FY2024 | Jun 30, 2024 | -$6.99M | – |
| Q1 FY2024 | Mar 31, 2024 | -$5.27M | – |
| Q4 FY2021 | Dec 31, 2021 | -$16.92M | – |
| Q3 FY2021 | Sep 30, 2021 | $2.83M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.21M | – |
| Q1 FY2021 | Mar 31, 2021 | -$18.94M | – |
| Q4 FY2020 | Dec 31, 2020 | -$6.96M | – |
| Q3 FY2020 | Sep 30, 2020 | -$11.46M | – |
| Q2 FY2020 | Jun 30, 2020 | -$14.27M | – |
| Q1 FY2020 | Mar 31, 2020 | -$11.05M | – |
| Q4 FY2019 | Dec 31, 2019 | -$12.68M | – |
| Q3 FY2019 | Sep 30, 2019 | -$22.38M | – |
| Q2 FY2019 | Jun 30, 2019 | -$8.04M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.06M | – |
| Q4 FY2018 | Dec 31, 2018 | -$8.32M | – |
| Q3 FY2018 | Sep 30, 2018 | -$9.60M | – |
| Q2 FY2018 | Jun 30, 2018 | -$13.10M | – |
| Q1 FY2018 | Mar 31, 2018 | -$8.94M | – |
| Q4 FY2017 | Dec 31, 2017 | -$10.18M | – |
| Q3 FY2017 | Sep 30, 2017 | -$8.20M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.13M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.28M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.23M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.45M | – |
| Q2 FY2016 | Jun 30, 2016 | -$3.03M | – |
| Q1 FY2016 | Mar 31, 2016 | -$1.99M | – |
See a number that looks wrong?